How many shares did Chemours director Mary B. Cranston receive in her latest equity grant, and when was it awarded?

Mary B. Cranston received an equity grant of 7,182 common shares on May 6th, as stated in the news body.

What is Mary B. Cranston's total shareholding in Chemours after the May 6th grant, and what types of units does it include?

After the May 6th grant, her total holdings amount to 106,830.0129 shares, including deferred stock units and dividend equivalent units, following an adjustment for a previous administrative error.

Chemours Director Granted 7,182 Company Shares

May 8, 2026

Chemours director Mary B. Cranston received 7,182 common shares as stock-based compensation on May 6th, increasing her total holdings to over 106,000 shares per Form 4 filing.

Stock Titan

2026-05-08

Chemours Director Granted Equity Award

2026-05-08

Chemours Director Erin Kane Granted 7,182 Stock Units

2026-05-08

Chemours Director Granted 7,182 Company Shares

2026-05-21

Chemours Petitions NC Supreme Court to Dismiss AG Jackson's Lawsuit

2026-06-03

Chemours Honors 2026 Catalyst for Scientific Excellence Award Winners